"","Key performance property","Max","NA"
"1","SMC program coverage [70% - 100%]","CLINICAL INCIDENCE","24% to 50%"
"2","SMC program coverage [70% - 100%]","SEVERE DISEASE","46% to 66%"
"3","Duration of protection [10 - 60 days]","CLINICAL INCIDENCE","31% to 53%"
"4","Duration of protection [10 - 60 days]","SEVERE DISEASE","10% to 34%"
"5","SMC round coverage [70% - 100%]","CLINICAL INCIDENCE","11% to 20%"
"6","SMC round coverage [70% - 100%]","SEVERE DISEASE","12% to 23%"
"7","Initial efficacy [80% - 100%]","CLINICAL INCIDENCE","3% to 8%"
"8","Initial efficacy [80% - 100%]","SEVERE DISEASE","1% to 4%"
